| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.97B | 54.29B | 51.23B | 50.16B | 46.48B | 46.23B |
| Gross Profit | 12.81B | 12.38B | 11.99B | 12.31B | 11.58B | 11.49B |
| EBITDA | 5.70B | 5.82B | 5.37B | 5.83B | 4.43B | 3.98B |
| Net Income | 3.81B | 3.53B | 3.17B | 3.46B | 2.79B | 2.99B |
Balance Sheet | ||||||
| Total Assets | 60.41B | 66.66B | 65.16B | 58.78B | 54.60B | 60.22B |
| Cash, Cash Equivalents and Short-Term Investments | 9.43B | 10.27B | 10.83B | 11.30B | 10.74B | 13.84B |
| Total Debt | 833.00M | 957.00M | 1.18B | 1.25B | 1.22B | 6.09B |
| Total Liabilities | 13.61B | 19.87B | 21.00B | 20.38B | 19.37B | 25.86B |
| Stockholders Equity | 46.80B | 46.79B | 44.16B | 38.40B | 35.23B | 34.36B |
Cash Flow | ||||||
| Free Cash Flow | 919.50M | 238.00M | 506.00M | 1.08B | 2.53B | 2.88B |
| Operating Cash Flow | 1.31B | 1.86B | 1.74B | 1.88B | 3.12B | 4.19B |
| Investing Cash Flow | -576.00M | 738.00M | -1.09B | -683.00M | 2.59B | -2.42B |
| Financing Cash Flow | -370.50M | -1.35B | -1.18B | -828.00M | -5.93B | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥46.39B | 7.34 | ― | 3.21% | 7.99% | 50.13% | |
80 Outperform | ¥28.23B | 13.32 | ― | 2.89% | 6.15% | 2.98% | |
80 Outperform | ¥78.44B | 8.26 | ― | 2.31% | 6.50% | 30.54% | |
79 Outperform | ¥55.14B | 10.04 | ― | 1.94% | -4.17% | -7.07% | |
75 Outperform | ¥34.08B | 13.64 | ― | 2.29% | 6.81% | 12.70% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥8.97B | 16.72 | ― | 2.45% | 15.66% | -69.17% |